Overview

Effect Of Exenatide Treatment on Liver Fat Content in Patients With Diabetes

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the effect of exenatide, an anti-diabetes medication, on liver fat and blood levels of proteins that influence liver fat.
Phase:
Phase 4
Details
Lead Sponsor:
Baylor College of Medicine
Treatments:
Exenatide
Pioglitazone